Page last updated: 2024-10-25

deferiprone and Bleeding

deferiprone has been researched along with Bleeding in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"Intramyocardial hemorrhage is an independent predictor of adverse outcomes in ST-segment elevation myocardial infarction (STEMI)."1.56Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction. ( Barry, J; Behrouzi, B; Connelly, J; Ghugre, NR; Manca, D; Qi, X; Rabadia, V; Spino, M; Strauss, BH; Weyers, JJ; Wood, JC; Wright, GA, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Behrouzi, B1
Weyers, JJ1
Qi, X1
Barry, J1
Rabadia, V1
Manca, D1
Connelly, J1
Spino, M1
Wood, JC1
Strauss, BH1
Wright, GA1
Ghugre, NR1

Other Studies

1 other study available for deferiprone and Bleeding

ArticleYear
Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction.
    Basic research in cardiology, 2020, 03-05, Volume: 115, Issue:3

    Topics: Animals; Cardiotonic Agents; Deferiprone; Disease Models, Animal; Female; Hemorrhage; Iron Chelating

2020